Pozzi, a professional in the field of packaging systems, has more than twenty years of experience.
As global markets continue to rally, with U.S. stocks reaching record highs amid optimism for softer tariffs and AI investments, growth stocks have notably outperformed value shares for the first time ...
Protheragen launches a full spectrum of ophthalmic drug preclinical R&D services to streamline the complex process of developing effective therapies for eye diseases. Protheragen, a reputable research ...
Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to ...
Naples, Italy-based rare diseases focused biotech BIOVIIIx says that its subsidiary Anbition and Japanese firm TagCyx ...
ISELIN, N.J. - Outlook Therapeutics, Inc. (NASDAQ:OTLK), a biopharmaceutical company with a current market capitalization of $50.3 million, announced the appointment of Faisal G. Sukhtian as Chairman ...
With its acceptance by the NMPA, NVK002 is now under regulatory review across three major global markets: the United States, the European Union, and China. This milestone reinforces Vyluma’s vision of ...
C2 PHARMA receives CEP approval from EDQM for oxybuprocaine hydrochloride: Cork, Ireland Thursday, January 30, 2025, 10:00 Hrs [IST] C2 PHARMA, the global leader in manufacturing ...
Steriline appoints Pozzi as CSeO to lead its after-sales service and customer support in aseptic processing lines for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results